Clinical Trials Directory

Trials / Completed

CompletedNCT01462305

30-Minute Light Exposure for the Treatment of Seasonal Affective Disorder

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
35 (actual)
Sponsor
Philips Respironics · Industry
Sex
All
Age
21 Years – 64 Years
Healthy volunteers
Not accepted

Summary

The primary objective of this study is to evaluate the effect of light therapy using a narrow 467nm light compared to a 580nm light in subjects with Seasonal Affective Disorder (SAD). It is hypothesized that the 467nm light will improve the symptoms of SAD better than the 580nm light.

Detailed description

Participants will be randomly assigned to receive either a 467nm light or a 580nm light. Participants will use the light every day for six weeks for 30 minutes. Multiple assessments and questionnaires will be given weekly to assess the efficacy of the treatment.

Conditions

Interventions

TypeNameDescription
DEVICEgoLITEgoLITE at 30 minutes per day, within 30 minutes of waking in the morning
DEVICEControllight therapy using 580nm LED source within 30 minutes of waking in the morning every day for 6 weeks

Timeline

Start date
2012-01-06
Primary completion
2012-04-02
Completion
2012-04-02
First posted
2011-10-31
Last updated
2019-01-30
Results posted
2019-01-30

Locations

4 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01462305. Inclusion in this directory is not an endorsement.

30-Minute Light Exposure for the Treatment of Seasonal Affective Disorder (NCT01462305) · Clinical Trials Directory